Variant report
Variant | nsv1054448 |
---|---|
Chromosome Location | chr12:84870138-84893729 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34508355 | chr12:84881815-84881816 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs373850786 | chr12:84881816-84881817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139436236 | chr12:84881888-84881889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150059813 | chr12:84881964-84881965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561532621 | chr12:84881966-84881967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7311282 | chr12:84882022-84882023 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs541278142 | chr12:84882028-84882029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527819734 | chr12:84882045-84882046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549513094 | chr12:84882051-84882052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567635008 | chr12:84882113-84882114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145466753 | chr12:84882175-84882176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550406770 | chr12:84882186-84882187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571885020 | chr12:84882187-84882188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539204552 | chr12:84882194-84882195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115355269 | chr12:84882376-84882377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183870781 | chr12:84891269-84891270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538222279 | chr12:84891286-84891287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535690722 | chr12:84891377-84891378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554747006 | chr12:84891399-84891400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146485809 | chr12:84891415-84891416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543570310 | chr12:84891430-84891431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372063587 | chr12:84891452-84891453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564908718 | chr12:84891480-84891481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141159195 | chr12:84891518-84891519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541287873 | chr12:84891524-84891525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559662784 | chr12:84891637-84891638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530227683 | chr12:84891644-84891645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11116427 | chr12:84891650-84891651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12827116 | chr12:84891735-84891736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144843177 | chr12:84891756-84891757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2611292 | chr12:84891790-84891791 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs11116428 | chr12:84891803-84891804 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs375833200 | chr12:84891819-84891820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116221306 | chr12:84891946-84891947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534608811 | chr12:84891974-84891975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113634217 | chr12:84892002-84892003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189088445 | chr12:84892059-84892060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368248742 | chr12:84892061-84892062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148922058 | chr12:84892077-84892078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143718605 | chr12:84892083-84892084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192833170 | chr12:84892094-84892095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs558636765 | chr12:84892114-84892115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148122760 | chr12:84892131-84892132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541075303 | chr12:84892137-84892138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185369856 | chr12:84892152-84892153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187475135 | chr12:84892159-84892160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140978627 | chr12:84892162-84892163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150255599 | chr12:84892203-84892204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531012286 | chr12:84892210-84892211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs367892222 | chr12:84892244-84892245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:84881800-84882400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr12:84891200-84893000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr12:84891600-84892000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr12:84893000-84896400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |